⚠️ Research Only — All content is for informational and research purposes. Not medical advice. Read full disclaimer

Noopept

Also known as: N-Phenylacetyl-L-Prolylglycine Ethyl Ester, GVS-111

Noopept is a synthetic nootropic peptide that enhances cognitive function through AMPA receptor modulation and BDNF upregulation. Research shows it improves memory formation, learning capacity, and neuroprotection at doses 100-1000 times lower than traditional racetams.

Last updated: February 18, 2026Reviewed by: PeptideHub Research Team

Noopept is a 318.37 g/mol research peptide. Noopept is a synthetic nootropic peptide that enhances cognitive function through AMPA receptor modulation and BDNF upregulation. Research shows it improves memory formation, learning capacity, and neuroprotection at doses 100-1000 times lower than traditional racetams.

Also called: N-Phenylacetyl-L-Prolylglycine Ethyl Ester, GVS-111

318.37 g/mol

Molecular Weight

Daltons

2

Strong Evidence

benefits

4

Studies Cited

peer-reviewed

10-30

Typical Dose

mg

Overview

Noopept represents a breakthrough in synthetic nootropic compounds, offering potent cognitive enhancement through multiple neurochemical pathways. This dipeptide analog crosses the blood-brain barrier efficiently and metabolizes into cycloprolylglycine, which drives its primary effects on glutamatergic neurotransmission. Unlike traditional racetams, Noopept demonstrates activity at microdoses while providing comprehensive neuroprotective benefits. The compound enhances both short-term working memory and long-term memory consolidation through AMPA receptor sensitization and increased brain-derived neurotrophic factor expression. Research applications focus on memory disorders, cognitive decline, and neuroplasticity enhancement protocols.

Key Takeaways: Noopept

  • Strongest evidence supports Noopept for memory enhancement and learning acceleration
  • Research doses typically range from 10 to 30 mg via oral
  • 2 benefits with strong evidence, 3 moderate, 2 preliminary
  • Half-life: 25-30 minutes
  • 4 cited research studies in this guide

Mechanism of Action

Noopept functions as an AMPA receptor positive allosteric modulator, increasing glutamate sensitivity without direct receptor binding. The active metabolite cycloprolylglycine upregulates BDNF and NGF expression, promoting synaptic plasticity and neurogenesis. Additional mechanisms include acetylcholine esterase inhibition, enhanced calcium-dependent protein kinase II activity, and modulation of voltage-gated calcium channels. These pathways collectively improve synaptic transmission efficiency and long-term potentiation.

Research Benefits

Noopept at a Glance

Primary mechanism:

Noopept functions as an AMPA receptor positive allosteric modulator, increasing glutamate sensitivity without direct receptor binding.

Top researched benefits:
Memory EnhancementLearning AccelerationNeuroprotectionCognitive RecoveryAttention and FocusAnxiety ReductionCerebral Blood Flow

Memory Enhancement

Strong Evidence

Improves both working memory and long-term memory consolidation through AMPA receptor modulation and increased synaptic plasticity.

Learning Acceleration

Strong Evidence

Enhances acquisition of new information and skill learning by optimizing glutamatergic neurotransmission and BDNF signaling.

Neuroprotection

Moderate Evidence

Protects neurons from oxidative stress and excitotoxicity while promoting neuronal survival through growth factor upregulation.

Cognitive Recovery

Moderate Evidence

Accelerates cognitive function restoration following brain injury or neurological insults by supporting neuroplasticity mechanisms.

Attention and Focus

Moderate Evidence

Improves sustained attention and cognitive control through enhanced prefrontal cortex function and neurotransmitter balance.

Anxiety Reduction

Preliminary

Demonstrates anxiolytic effects independent of sedation, potentially through GABA system modulation and stress hormone regulation.

Cerebral Blood Flow

Preliminary

Increases regional cerebral blood flow and oxygen utilization, supporting optimal brain metabolism and function.

Evidence Key:
Strong EvidenceMultiple human trials
Moderate EvidenceLimited human / strong preclinical
PreliminaryEarly research
AnecdotalCommunity reports

Research Dosing Protocols

Research Purposes Only: All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.

Research ProtocolDose RangeRoute
General cognitive enhancement1030 mgoral
Memory research2040 mgoral
Neuroprotection studies3060 mgoral

Frequency

1-2 times daily

Timing

Morning and early afternoon with or without food

Cycle Length

8-12 weeks with 2-4 week breaks

Research Notes

  • 1Start with lowest effective dose due to high potency
  • 2Effects may accumulate over several days of consistent use
  • 3Avoid evening doses due to potential sleep disruption
  • 4Sublingual administration may increase bioavailability

Reconstitution Guide

Standard Reconstitution

Vial Size

0 mg

Bacteriostatic Water

0 mL

Concentration

NaN mcg

per 0.1 mL (10 units)

Step-by-Step Guide

1

Gather Materials

Noopept vial, bacteriostatic water, alcohol swabs, insulin syringes.

2

Equilibrate Temperature

Remove the vial from storage and allow it to reach room temperature (5-10 minutes).

3

Sanitize

Swab the rubber stopper of both the peptide vial and bacteriostatic water vial with alcohol.

4

Draw Water

Draw 0 mL of bacteriostatic water into a syringe.

5

Add Water to Vial

Insert the needle into the peptide vial and direct the water stream against the glass wall — not directly onto the powder.

6

Mix Gently

Swirl the vial gently until the powder is fully dissolved. Never shake. The solution should be clear and colorless.

7

Store Properly

Refrigerate at Room temperature. 2-3 years.

Storage Temperature

Room temperature

Shelf Life

2-3 years

Important Notes

  • Supplied as powder for oral administration
  • Store in cool, dry place away from light
  • No reconstitution required - not an injectable peptide

Safety & Side Effects

Reported Side Effects

  • !Headaches (most common, often dose-dependent)
  • !Insomnia or sleep disturbances
  • !Irritability or mood changes
  • !Nausea or gastrointestinal upset
  • !Fatigue or mental exhaustion
  • !Dizziness or lightheadedness
  • !Increased blood pressure
  • !Restlessness or agitation
  • !Metallic taste
  • !Brain fog (paradoxical effect at high doses)

Potential Interactions

  • May potentiate effects of other nootropics and stimulants
  • Could interact with ADHD medications (amphetamines, methylphenidate)
  • May enhance effects of racetam-class compounds
  • Potential interactions with blood pressure medications
  • Could affect anticoagulant medication effectiveness

Important: Side effects and interactions listed here are compiled from published research and community reports. This is not a complete list. No formal drug interaction studies have been conducted for most research peptides. Always consult a qualified healthcare provider.

Research Studies

The following studies are referenced in this profile. PubMed IDs are provided where available for independent verification.

Noopept and its active metabolite cycloprolylglycine improve memory formation and retrieval

Ostrovskaya RU, Gruden MA, Bobkova NA2007Behavioural Pharmacology

Demonstrated Noopept's superior memory-enhancing effects compared to piracetam, with active metabolite identification and mechanism elucidation.

Neuroprotective and cognition-enhancing effects of Noopept in experimental models

Pelsman A, Hoyo-Vadillo C, Gudasheva TA2009European Journal of Pharmacology

Showed neuroprotective effects against glutamate excitotoxicity and cognitive improvements in animal models of brain damage.

AMPA receptor modulation by Noopept and related compounds

Vorobyov V, Kapai NA, Nerobkova LN2011Neuropharmacology

Identified AMPA receptor positive allosteric modulation as a primary mechanism underlying Noopept's cognitive effects.

Clinical efficacy of Noopept in mild cognitive impairment

Neznamov GG, Teleshova ES2009Neuroscience and Behavioral Physiology

Human clinical trial demonstrating cognitive improvements in patients with mild cognitive impairment over 56 days of treatment.

Note: This is not an exhaustive list of all published research. Studies are selected for relevance and quality. Click PubMed IDs to verify sources independently. Inclusion does not imply endorsement of the peptide for any clinical use.

Frequently Asked Questions

Acute effects may be noticed within 15-30 minutes of administration, but optimal cognitive benefits typically develop over 7-14 days of consistent use. The compound has a short half-life but produces lasting metabolites that accumulate with regular dosing.

Noopept is significantly more potent than racetam compounds, requiring doses 100-1000 times smaller for similar effects. However, 'stronger' depends on individual response and specific cognitive goals. Its unique mechanism offers different benefits compared to other nootropic classes.

Noopept can be combined with caffeine, but start with reduced doses of both compounds. The combination may increase stimulation and focus but also raises the risk of jitters, anxiety, or sleep disruption. Monitor your response carefully.

Noopept is 100-1000 times more potent than piracetam and works through AMPA receptor modulation rather than AMPA receptor activation. It also has better bioavailability, shorter half-life, and additional neuroprotective mechanisms through BDNF upregulation.

Cycling is recommended - typically 8-12 weeks on followed by 2-4 weeks off. This prevents potential tolerance development and allows assessment of baseline cognitive function. Continuous use may reduce effectiveness over time.

Headaches are the most common side effect, often indicating acetylcholine depletion or increased brain metabolism demands. Try reducing the dose, ensuring adequate hydration, or adding a choline source like alpha-GPC or CDP-choline.

Sublingual administration may provide faster onset and potentially higher bioavailability by bypassing first-pass liver metabolism. However, oral bioavailability is already very high at 99.7%, so the difference may be minimal for most users.

Research suggests Noopept may improve attention and focus through glutamatergic modulation, but it's not a replacement for ADHD medications. Some users report benefits, but individual responses vary significantly and medical supervision is recommended.

⚠️

Research & Educational Use Only

All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.

The information presented here is compiled from published research studies and is intended for informational purposes only. Individual results may vary. Always consult with a licensed healthcare provider.